HYPD Stock Analysis: Buy, Sell, or Hold?
HYPD - Hyperion DeFi, Inc. Common Stock
$3.61
-0.09 (-2.43%)
▼
5d:
+0.28%
30d:
-19.78%
90d:
+12.46%
BUY
HIGH Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 14, 2026
0d
Get Alerted When HYPD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called HYPD this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: HYPD shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: HYPD shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$0.49
Based on -25.1% avg growth
INTRINSIC VALUE TODAY
$0.30
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HYPD is currently trading at $3.61, which is considered fair relative to its 30-day fair value range of $3.43 to $4.16. From a valuation perspective, the stock is trading at a premium (Forward PE: 9.5) compared to its historical average (6.7). At these levels, the market is pricing in 12.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, HYPD is in a uptrend. Immediate support is located at $3.16, while resistance sits at $4.09.
Market Sentiment: HYPD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.12 (+69.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HYPD is in a uptrend. Immediate support is located at $3.16, while resistance sits at $4.09.
Market Sentiment: HYPD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.12 (+69.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.43 -
$4.16
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.4%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 69.7% below Wall St target ($6.12)
- NEUTRAL: Trading at premium valuation - market expects 12.2% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$3.43 -
$4.16
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.16
Resistance Level
$4.09
Current Trend
Uptrend
Technical data as of
Jun 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.50
Wall Street Target
$6.13
(+69.7%)
Revenue Growth (YoY)
1559.5%
Valuation Premium vs History
+12.2% premium
PE vs Historical
9.5 vs 6.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+12.2%
(market-implied from PE analysis)
1-Year Target
$4.05
(+12%)
2-Year Target
$4.54
(+26%)
3-Year Target
$5.10
(+41%)
3-Yr Target (if PE normalizes)
(PE: 10→7)
PE COMPRESSION
$3.60
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.9, Growth: -54.2%)
$6.07
(+68%)
Base:
(SPY PE: 9.5, Growth: -54.2%)
$2.63
(-27%)
Bear:
(PE: 6.7, Growth: -54.2%)
$1.86
(-49%)
Share & Embed Analysis
Last updated: June 03, 2026 5:23 PM ET
Data refreshes hourly during market hours. Next update: 6:23 PM
Data refreshes hourly during market hours. Next update: 6:23 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HYPD showing a specific setup today?
Insider Activity (6 Months)
9
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
David R Knox
BUY
27950 shares
2025-12-31
Ellen R Strahlman
BUY
12112 shares
2025-12-29
Ellen R Strahlman
BUY
11856 shares
2025-12-29
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$446 | 60 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 54 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1023 | 53 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$82 | 58 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$297 | 57 HOLD |
